Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3.
Published February 15, 2017 · Recall initiated: December 19, 2016
Summary
FDA records drug Class III recall D-0471-2017, published February 15, 2017 and initiated December 19, 2016. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 67,946 bottles; Lot: Lot #: MJ7746, Exp 04/17. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: Product may not meet specifications throughout shelf life.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Apotex Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot #: MJ7746, Exp 04/17
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAMetformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only Manufactured by:June 24, 2020
- FDAEquate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets Distributed by Wal-MartNovember 20, 2019
- FDAPiperacillin and Tazobactam for Injection, USP 3.375 gram/vial* 10-count Single Use Vials per carton, Rx Only,May 23, 2018
- FDAPiperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only,May 23, 2018
- FDAPantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: AuromedicsFebruary 15, 2017
- FDACappuccino Snack Mix Lot code: 20161027; Best By: 05/25/17 Net Wt: 10 lb (2-5lb bags)February 15, 2017
Questions about this recall
Was Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3. recalled?
Yes. FDA published recall D-0471-2017 on February 15, 2017. Reported hazard: Superpotent Drug: Product may not meet specifications throughout shelf life.
What should I do if I have this product?
Voluntary: Firm initiated · Letter